
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
SWK Holdings Corp (SWKH)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: SWKH (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $18
1 Year Target Price $18
0 | Strong Buy |
1 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -14.9% | Avg. Invested days 46 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 180.85M USD | Price to earnings Ratio 10.45 | 1Y Target Price 18 |
Price to earnings Ratio 10.45 | 1Y Target Price 18 | ||
Volume (30-day avg) 1 | Beta 0.2 | 52 Weeks Range 11.99 - 16.23 | Updated Date 06/30/2025 |
52 Weeks Range 11.99 - 16.23 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.41 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 50.3% | Operating Margin (TTM) 66.68% |
Management Effectiveness
Return on Assets (TTM) 5.37% | Return on Equity (TTM) 6.13% |
Valuation
Trailing PE 10.45 | Forward PE - | Enterprise Value 188624221 | Price to Sales(TTM) 5.18 |
Enterprise Value 188624221 | Price to Sales(TTM) 5.18 | ||
Enterprise Value to Revenue 4.15 | Enterprise Value to EBITDA 6.42 | Shares Outstanding 12269600 | Shares Floating 2347054 |
Shares Outstanding 12269600 | Shares Floating 2347054 | ||
Percent Insiders 6.38 | Percent Institutions 87.47 |
Analyst Ratings
Rating 1 | Target Price 18 | Buy 1 | Strong Buy - |
Buy 1 | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
SWK Holdings Corp
Company Overview
History and Background
SWK Holdings Corporation, established in 2010, is a specialized finance company focused on the healthcare sector. It provides flexible financing solutions to healthcare companies across a range of industries.
Core Business Areas
- Direct Lending: SWK originates and structures loans to healthcare companies requiring capital for acquisitions, growth, recapitalizations, and other strategic initiatives. Direct lending to life science companies focused on pharma and medical device royalties.
- Structured Finance: This segment involves providing more complex financial solutions tailored to specific client needs, often involving royalty monetization or other structured investments.
- Medical Royalty Monetization: SWK provides funds to life sciences companies or inventors in exchange for the right to receive a stream of future royalties from products. This allows the life sciences companies to secure immediate capital infusion from their royalty assets.
Leadership and Structure
The leadership team includes Winston Black (CEO), Jody Staggs (CFO). The organizational structure is centered around its core business areas, with teams dedicated to origination, underwriting, portfolio management, and finance.
Top Products and Market Share
Key Offerings
- Direct Lending: Provides loans to healthcare companies for various purposes. Market share data is not publicly available. Competitors include private credit funds and other specialized lenders. Revenue contributed a significant portion of total revenue.
- Royalty Monetization: Acquires royalty streams from pharmaceutical and medical device products. Market share data not publicly available. Competitors include Royalty Pharma and other royalty monetization firms. Represents a substantial revenue stream.
Market Dynamics
Industry Overview
The healthcare finance industry is experiencing growth driven by increasing demand for capital to fund innovation, acquisitions, and expansion. The industry is fragmented with a mix of traditional lenders and specialized finance companies.
Positioning
SWK Holdings is positioned as a specialized lender focused on the healthcare sector, offering flexible and tailored financing solutions. Competitive advantage lies in its deep industry knowledge and ability to structure complex deals.
Total Addressable Market (TAM)
The TAM for healthcare finance is estimated to be in the hundreds of billions of dollars annually. SWK Holdings is positioned to capture a share of this market by focusing on specialized niches within healthcare, particularly in royalty monetization and direct lending to life science companies.
Upturn SWOT Analysis
Strengths
- Specialized industry knowledge
- Flexible financing solutions
- Experienced management team
- Strong underwriting capabilities
Weaknesses
- Concentration in the healthcare sector
- Small size compared to larger financial institutions
- Reliance on external funding sources
Opportunities
- Growing demand for healthcare financing
- Expansion into new healthcare sub-sectors
- Strategic acquisitions
- Increasing regulatory complexity
Threats
- Economic downturns
- Changes in healthcare regulations
- Increased competition
- Rising interest rates
Competitors and Market Share
Key Competitors
- PSEC
- TROW
- IVZ
Competitive Landscape
SWK Holdings is a smaller player compared to its larger competitors. It differentiates itself through its specialized healthcare focus and flexible financing solutions.
Growth Trajectory and Initiatives
Historical Growth: Historical Growth trends can be found in historical financial data. Requires access to current financial data, refer to their financial reports for the most up to date values.
Future Projections: Future projections will be based on company guidance and market trends analysis.
Recent Initiatives: Focus on royalty monetization and specialty finance opportunities; also expanding into new healthcare verticals.
Summary
SWK Holdings is a specialized finance company in the healthcare sector that offers flexible funding solutions. It shows consistent financial performance, strong in royalty monetization, direct lending, and strategic management. SWK Holdings faces risks from industry fluctuations, economic downturns, and increasing regulation, but also benefits from industry expertise and growth opportunities in expanding healthcare areas and strategic acquisitions.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Third-party financial data providers
- Industry reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on thorough research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About SWK Holdings Corp
Exchange NASDAQ | Headquaters Dallas, TX, United States | ||
IPO Launch date 1999-09-22 | CEO & President Mr. Jody. D Staggs | ||
Sector Financial Services | Industry Asset Management | Full time employees 26 | Website https://www.swkhold.com |
Full time employees 26 | Website https://www.swkhold.com |
SWK Holdings Corporation is a principal investment firm. The firm prefers to invest in healthcare, biopharma, medical devices, diagnostics, life science tools and healthcare service sectors. The firm prefers to invest between $5 million and $20 million transactions. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was incorporated in 1996 and is headquartered in Dallas, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.